Cardiovascular Medicine and Haematology articles for China

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 359

Article ‘Count’ for Cardiovascular Medicine and Haematology.

Journal Count Share
17 15.53
A Lung-Targeted Carrier of Carbon Monoxide for Idiopathic Pulmonary Fibrosis Therapy 1.00
Lung-Accumulating Mucin 5AC Silencing by Noninflammatory Lipid Nanoparticles for Asthma Treatment 0.95
Reprogramming Lesional Macrophage Homeostasis via Interferon Regulatory Factor 5 Targeted siRNA Nanoimmunotherapy for Atherosclerosis 0.60
Biomimetic Selenium-Encrusted Prussian Blue Nanozyme for Myocardial Infarction by Coordinated Enhancement of Mitophagy and Reactive Oxygen Species Scavenging 1.00
D-Mannose-Modified M2 Macrophage Membrane-Derived Decoy Nanovesicles for Synergistic Immunotherapy of Asthma 1.00
In Situ Reprogramming of Senescent Microenvironment via Augmentation of Endogenous Senolytic Actions for Advanced Atherosclerosis Management 1.00
In Vivo Immunomodulatory Programming of Circulating Myeloid Cells via Itaconic Acid Liposomes to Mitigate Myocarditis 1.00
Biomimetic Macrophages Inhibit Atherosclerosis in ApoE–/– Mice through Inducing Macrophages Autophagy 1.00
Inhalation of Mesenchymal-Stem-Cell-Derived Nanovesicles Delivering Catalase Enhances the Treatment for Acute Lung Injury 1.00
Tactile-Transparent Wearable Sensor for Clinician-Friendly Pulse Wave Velocity Monitoring and Cardiovascular Risk Profiling 1.00
Passive Monitoring to Active Regulation: Closed-Loop Piezoelectric Theranostic Platform Enabling On-Demand Vagus Stimulation for Terminating Inappropriate Sinus Tachycardia 1.00
Cardiomyocyte-Based Multimodal Biosensing Platform for Dynamic Functional Assessment of Bioinspired Engineered Respiratory Virus-Induced Myocarditis 1.00
Homotransplantation of Engineered Macrophages with Surface-Modified Nanomedicines for Mitigating Myocardial Ischemia–Reperfusion Injury 1.00
Tolerogenic Dendritic Cell- and M2 Macrophage Polarization-Inducible Hybrid Nanoparticles Alleviate Asthma in Mice 0.11
Targeting Senescent Alveolar Type 2 Cells with a Gene-Editable FePt Dual-Atom Catalyst for Mitigating Idiopathic Pulmonary Fibrosis 1.00
Sprayable Reactive Oxygen Species-Responsive Hydrogel Coatings Restore Endothelial Barrier Integrity for Functional Vascular Healing 1.00
Targeted Knockdown of Epithelial Estrogen Receptor α to Mitigate Ferroptosis and Epithelial–Mesenchymal Transition in Eosinophilic Asthma 0.87
8 7.02
Multi-targeted ROS-responsive self-immolative nanoparticles for releasing hydrogen sulfide and in situ binding of Cell-Free DNA in blast-induced acute lung injury 1.00
Mechanical characterization of infarcted porcine hearts using left anterior descending and left circumflex coronary artery models 0.02
Inhaled biomimetic nanoparticles enhance pulmonary delivery of tetrandrine and pirfenidone for the treatment of idiopathic pulmonary fibrosis 1.00
A photodriven nano-extinguisher alleviates acute bacterial infections via toll-like receptor 4-regulated immune response 1.00
Nanoparticles coated with immune cell hybrid membranes for targeted delivery of janus kinase inhibitors and synergistic treatment of autoimmune myocarditis 1.00
Injectable protein hydrogel microspheres with reactive oxygen species-responsive nitric oxide release for cardiac protection against ischemia/reperfusion injury 1.00
Remodeling the blood-air barrier and enhancing the pulmonary microcirculation with a dual-responsive biomimetic nanosystem for precise therapy in acute lung injury 1.00
Dual delivery of agmatine and microRNA-126b using agmatine-mediated DNA nanotube assemblies for acute lung injury therapy 1.00
5 4.83
Dual-Defect Engineering of LDH-Based Nanozymes to Enhance Antioxidative Effects in Ischemia Stroke-Reperfusion Injury 1.00
Inhalable Lipid Nanoparticles with Mucus Clearance and ROS Scavenging Properties for Acute Lung Injury Treatment 1.00
A Biomimetic Epidermal Sensing Sucker via Stress Excitation for Personalized Cardiovascular Monitoring 0.83
Engineered Iontophoresis Patch for Epicutaneous Allergen‐specific Immunotherapy 1.00
Bifunctional Peptide‐Engineered Mitochondria Alleviate Myocarditis and Cardiac Fibrosis by Site‐Specifically Inhibiting NETosis 1.00
1 0.95
An Extravascular Synergistic Cocktail Therapeutic Strategy Based on Lanifibranor Loaded Self-Healing Bioelastomer for Abdominal Aortic Aneurysms 0.95
1 0.33
Interaction between dietary cholesterol intake and genetic variants for cholesterol absorption in relation to coronary artery disease mortality: a prospective analysis in the Singapore Chinese Health Study 0.33
2 2.00
Cullin 2 elevates Warburg effect to accelerate the development of hypoxic pulmonary hypertension 1.00
The substructure of the endothelial glycocalyx in rat aorta and its interaction with the low-density lipoproteins (LDL) 1.00
3 1.89
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension 0.04
A Large-Scale Single-Cell Atlas Reveals the Peripheral Immune Panorama of Bacterial Pneumonia. 0.95
Deficient FANCL Predisposes Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension. 0.90
13 13.00
Orthogonal NIR/Ratiometric Probe for Simultaneous Imaging of NO and ATP in Acute Lung Injury: Elucidating Metabolic Dysregulation and Therapeutic Screening 1.00
Fluorescent G-Quadruplex Nanowire-Enabled One-Pot Detection of Multiple Acute Myocardial Infarction-Related miRNAs 1.00
Real-Time Monitoring of Intraplaque Furin in Atherosclerotic Mice during Pneumonia and Dexamethasone Treatment 1.00
Surface Acoustic Wave-Based Assessment of Red Blood Cell Viability Following Cryopreservation 1.00
Wash-Free and Simultaneous Imaging Assay of PCSK9 and ApoB Proteins for Efficient Screening and Efficacy Evaluation of the PCSK9 Inhibitors 1.00
A Superoxide Anion-Responsive NIR Fluorogenic Probe Unravels Aucubin’s Dual-Axis Therapeutic Mechanism in Hypoxic Pulmonary Hypertension via Ferroptosis Suppression and Oxidative Injury Mitigation 1.00
Near-Infrared Fluorogenic Probe Enables Real-Time Imaging of HOCl to Reveal MAR1-Mediated Suppression of Pyroptosis in Limb Ischemia-Reperfusion Injury 1.00
Shear Stress-Induced Microstructure Remodeling of Human Bicuspid Aortopathy Revealed by Nonlinear Optical Microscopy 1.00
Etiology-Agnostic Diagnosis of Early Myocardial Ischemia via AI-Driven Label-Free Spectral Histopathology 1.00
Doxorubicin-Induced Toxicity and Bisoprolol-Protective Efficacy for Cardiomyocytes Monitored by Scanning Electrochemical Microscopy 1.00
Nanopore-Based Strategy for Single-Nucleotide Mutation Detection in Sickle Cell Disease Using Anthracycline Probes 1.00
Chronofluorometry Based on a Facile Fluorescent Probe for Rapid Detection of Fractional Exhaled Nitric Oxide and Bioimaging in Live Cells 1.00
Development and Validation of a Nitric Oxide-Responsive Optical Probe for Cardiovascular Disease with Acute Lung Injury In Vivo Imaging 1.00
2 1.25
Lighting up Ferroptosis Propagating via the Lung‐Heart Axis Exacerbates Cardiovascular Disease Through in Situ Imaging 1.00
Self‐Assembled Metal‐Polyphenol Colchicine Nanoparticles Targeting Oxidative Stress and Inflammation for Treatment of Atherosclerosis 0.25
1 0.79
Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study. 0.79
1 0.03
Altered AP-1, RUNX, and EGR chromatin dynamics drive human fibrotic lung disease 0.03
4 4.00
Label-free, high-spatiotemporal resolution microwave-induced thermoacoustic imaging for functional cardiac phenotyping and myocarditis detection 1.00
Pulse wave signal analysis and finding the quantitative indicators of cardiovascular health 1.00
A quick prediction for the transformation of red blood cell morphology with deep learning technique 1.00
Deep learning reveals direct correlation between red blood cell morphology and deformability 1.00
1 1.00
The Current Status of Cardiac Rehabilitation in China: A Cross-sectional National Survey 1.00
2 1.90
Interleukin‐33 Promotes Interstitial Lung Disease in Idiopathic Inflammatory Myopathy via ERK‐Mediated Epithelial‐Mesenchymal Transition: ERK as a potential therapeutic target 1.00
Activin A‐activated ALK4 induces pathogenic Th17 involved endothelial–mesenchymal transition in systemic lupus erythematosus‐associated pulmonary arterial hypertension 0.90
2 1.05
An optimized CRISPR-Cas12a genome-wide screen reveals PTPA phosphatase pathway in fetal hemoglobin silencing 0.05
Ruxolitinib Targets JAK-STAT Signaling to Modulate Neutrophil Activation in Refractory Macrophage Activation Syndrome 1.00
1 1.00
Gut-microbiota-derived indole sulfate promotes heart failure in chronic kidney disease 1.00
1 0.11
Cystine import and oxidative catabolism fuel vascular growth and repair via nutrient-responsive histone acetylation 0.11
2 1.97
Injury-induced Clusterin+ cardiomyocytes suppress inflammation and promote regeneration in neonatal and adult hearts by reprogramming macrophages 0.97
Targeting lysozyme 2 in endocardium promotes rapid recovery by modulating remote injury signals 1.00
3 2.94
Dual-site recognition leads to a ratiometric fluorescent probe for norepinephrine: quantitative detection and visualization for in-depth understanding of hypertension 0.94
A natural ultrasound-triggered nitric oxide booster for endothelial dysfunction therapy 1.00
A malondialdehyde-activated fluorescent probe reveals lysosomal dysfunction in atherosclerosis 1.00
7 6.05
Rare variants in PAH-related genes associate with a distinct vasculopathy phenotype and worse outcomes in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension 1.00
Clinical Validation of a Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease in Chinese 0.96
Developing and Validation of a Multimodal-based Machine Learning Model for Diagnosis of Usual Interstitial Pneumonia: a Prospective Multicenter Study 1.00
Clustering Patients With Chronic Cough Using Reported Sensations and Triggers: Results from the Triggers and Sensations Provoking Coughing Questionnaire 0.08
Deep Learning-Enhanced Non-Invasive Detection of Pulmonary Hypertension and Subtypes via Chest Radiographs, Validated by Catheterization 1.00
Discriminative Accuracy of the Simplified Spirometry for Identifying Spirometry-defined Chronic Obstructive Pulmonary Disease in Community 1.00
Lung Function Decline and Airflow Limitation Risk in Preserved Ratio Impaired Spirometry (PRISm) Subtypes by Smoking Status. 1.00
25 18.60
Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial. 1.00
CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy 1.00
TRIM28 Is an E3 Ligase of IRP2 Suppressing Ischemia/Reperfusion-Induced Myocardial Ferroptosis. 1.00
Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation. 0.50
CCR8 Expression on Regulatory T Cells Reveals Trajectories of Tissue Adaptation and Protects Against Myocardial Infarction-Induced Tissue Damage. 1.00
Inhibition of Annexin A2 Facilitates PHB2-Mediated Mitophagy in Cardiomyocytes to Alleviate Cardiac Injury and Remodeling After Infarction. 1.00
Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair. 1.00
Macrophage-Specific E3 Ubiquitin Ligase TRIM31 Reduces Atherosclerotic Plaque Formation by Targeting LOX-1. 1.00
S-Nitrosylation of Pyruvate Kinase Isoform 2 Drives Cardiac Fibrosis by Promoting Mitochondrial Fission. 1.00
Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial. 0.93
IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis. 0.75
Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial. 0.29
Bailout Intracranial Angioplasty or Stenting After Thrombectomy for Acute Large Vessel Occlusion: 1-Year Outcomes of ANGEL-REBOOT. 0.96
ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury. 1.00
Transcatheter Closure of Patent Foramen Ovale With a Novel Biodegradable Device: A Prospective, Multicenter, Randomized Controlled Clinical Trial. 1.00
PYGM Protects Against Myocardial Infarction by Enhancing Glycogenolysis and Facilitating Autophagic Flux. 1.00
TAX1BP3 Is a SUMOylated Nucleocytoplasmic Shuttling Protein and Protects Against Vascular Neointimal Hyperplasia. 0.90
TBX5 and CHD4 Coordinately Activate Atrial Cardiomyocyte Genes to Maintain Cardiac Rhythm Homeostasis. 0.10
G Protein-Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice. 0.97
Single-Cell Multi-Omics Identifies Specialized Cytotoxic and Migratory CD8+ Effector T Cells in Acute Myocarditis. 1.00
Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights From Genetic and Experimental Models. 0.05
Effect of Remote Ischemic Preconditioning on Myocardial Injury in Noncardiac Surgery: the PRINCE Randomized Clinical Trial. 0.04
Disruption of cTnT-Mediated Sarcomere-Mitochondrial Communication Results in Dilated Cardiomyopathy. 0.94
METTL3 Is Essential for Exercise Benefits in Diabetic Cardiomyopathy. 0.13
CD206+IL-4Rα+ Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy. 0.04
1 0.03
Plasma Levels of Soluble ST2 Reflect Extrapulmonary Organ Dysfunction and Predict Outcomes in Acute Respiratory Failure. 0.03
1 0.03
International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL. 0.03
9 8.71
C3a-C3ar1 axis mediates macrophage M1 polarization to drive silicosis inflammation and fibrosis 1.00
U-shaped Association Between Outdoor Artificial Light at Night Exposure and Metabolic Syndrome in Chinese Youth: Findings from a Nationally Representative Study 1.00
TRPA1 mediates ozone-induced murine model of COPD through the Wnt5a/GSK-3β/β-catenin pathway 0.83
Co-exposure to multiple fine particulate matter constituents and adults obstructive sleep apnoea (OSA) in Southern China 0.88
Benzo(a)pyrene exposure aggravates airway remodeling in asthma by activating AhR-GDF15 pathway in epithelial cells 1.00
Global distribution and evolutionary trends of the PM2.5 health burden predicted with a Geographically Neural Network Weighted Regression model 1.00
Protective Role of DsbA-L in COPD: Alleviating ER Stress-Induced Apoptosis Through AMPK Activation 1.00
Associations of environmental toxicant exposure with adult sleep problems and the mediating roles of inflammation 1.00
Silica-induced innate immune activation drives macrophage pyroptosis and lung inflammation through glycolytic reprogramming 1.00
6 4.81
Endoplasmic reticulum stress mediates oxidative stress-driven endothelial impairment and atherogenesis induced by sodium perfluorononenoxybenzene sulfonate exposure 0.64
Trajectories of Meteorological and Air Pollution Exposures during pregnancy and risk of Childhood Asthma: A Population-Based Cohort Study 0.95
Interaction between airway inflammation and gut microbiota dysbiosis caused by high temperatures (40 °C) and traffic-PM2.5 in mouse model 1.00
Effects of Per- and polyfluoroalkyl substances on atherosclerosis: an evidence-based risk assessment in the context of the TRAEC strategy 1.00
Impact of Ambient Ozone Exposure on Cardiac Biomarkers in Heart Failure and the Role of Sodium-glucose Cotransporter-2 Inhibitors: Findings from the TRACER-HF Trial 0.50
Exposure-effect of PFOS and PFOA on lung function: An integrated approach with epidemiological, cellular, and animal studies 0.71
5 3.82
Implications of Off-Peak Commercial Deliveries for Air Quality and Environmental Justice 0.04
Ozone Exposure (Outdoor–Indoor–Personal) and Mental Health in Young Adults 0.91
Intracranial Hemorrhage in Zebrafish: An Adverse Outcome Induced by Lovastatin 1.00
Environmentally Relevant Levels of Ozone Enhance iKlebsiella pneumoniae/i Pulmonary Colonization and Cross-Organ Translocation 1.00
Exposure to Anthropogenic Heat Was Associated with the Increased Risks of Respiratory Allergy Symptoms in Preschool Children: A New Insight into the Urban Heat Island Effect 0.87
25 16.15
New-onset postoperative atrial fibrillation management and outcomes: the VISION Cardiac Surgery cohort 0.04
Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry 0.03
SLC4A3-related short QT syndrome assessed in human induced pluripotent stem cell-derived cardiomyocytes: mechanisms of ventricular arrhythmia and sudden cardiac death 0.08
Nuclear AGO2 exacerbates heart failure with preserved ejection fraction through myocardial ketogenesis 1.00
Macrophage SBK2 suppresses inflammation and atherosclerosis by NLRP3 phosphorylation 1.00
Soluble ST2 drives fulminant myocarditis progression via the IGF2R–YY1 mitochondrial axis 0.90
Peripheral autonomic dysregulation in response to standing: a new form associated with cardiovascular disease, mobility reduction, and cognitive alterations 0.13
Frozen elephant trunk for acute type A aortic dissection: long-term outcomes over two decades 0.70
Left bundle branch vs biventricular pacing: mechanistic insights from a canine model 0.90
Atherosclerotic progression at sites of low shear stress is attenuated by myeloid-PlexinD1 deficiency through suppression of classical macrophage polarization 1.00
Digital profile of children’s hearts: automated echocardiogram strain analysis facilitates earlier detection of cardiac dysfunction 1.00
Oestrogen-related receptor γ in sepsis-induced cardiomyopathy: role of cardiomyocyte subtype conversion 1.00
Osimertinib induces reversible cardiac dysfunction through the GATA4-MYLK3-MYL2 axis 0.06
The macrophage-derived motor protein KIF13B enhances MERTK-mediated efferocytosis and prevents atherosclerosis in mice 1.00
Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international study 0.32
Enhanced antigen presentation by macrophages promotes human atherosclerosis progression: therapeutic implications 1.00
Outcomes of moderate mixed aortic valve stenosis and regurgitation 0.11
EP4/ANXA2 axis in pulmonary arterial hypertension: therapeutic implications 0.91
Early antiplatelet treatment for minor stroke following thrombolysis: the EAST trial 0.92
Endothelial plasticity in atrial fibrosis by integrating single-cell sequencing and genetic lineage tracing 1.00
Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial 1.00
Cardiovascular benefit of continuous positive airway pressure according to high-risk obstructive sleep apnoea: a multi-trial analysis 0.02
Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial 1.00
Colchicine for secondary prevention of vascular events: a meta-analysis of trials 0.04
Checkpoint kinase Wee1 activation drives inflammation and hypertrophy through the protein kinase B/phosphoinositide 3-kinases–nuclear factor κB pathway in cardiomyocytes 1.00
1 1.00
Parecoxib sequential with imrecoxib for occurrence and remission of severe acute pancreatitis: a multicentre, double-blind, randomised, placebo-controlled trial 1.00
1 1.00
Ovarian function compromise in pediatric beta-thalassemia major: a consequence of iron overload-induced mitochondrial and fibrotic damage 1.00
2 1.60
Dectin-1 facilitates lung fungal-mediated pulmonary fibrosis 0.83
A brain-to-lung signal from GABAergic neurons to ADRB2+ interstitial macrophages promotes pulmonary inflammatory responses 0.76
2 1.75
Circulating lipid subfractions and the risk of longitudinal adiposity progression: findings from the China Kadoorie Biobank 0.75
Age-dependent obesity paradox in acute myocardial infarction prognosis: a cohort study of body mass index and recurrent myocardial infarction 1.00
1 0.96
Liraglutide in Acute Minor Ischemic Stroke or High-Risk Transient Ischemic Attack With Type 2 Diabetes 0.96
1 0.91
Global Prevalence of Hypertension in Children and Adolescents Younger Than 19 Years 0.91
4 3.08
Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma 1.00
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia 0.08
Bioresorbable vs Metallic Occluders for Transcatheter Atrial Septal Defect Closure 1.00
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps 1.00
9 7.97
Neuroprotective Role of Nrf2 Activation Against ER Stress–Mediated Apoptosis in Obstructive Sleep Apnea 1.00
Farnesyl Pyrophosphate Synthase Promotes Restenosis After Vascular Injury by Activating Small G Proteins 1.00
Structural Insights into Hormone Recognition and G-Protein Coupling of the Urotensin-II Receptor 1.00
Suppression of SREBP by a transmembrane protein mutated in cardiomyopathy 0.11
The metastasis-associated protein MTA3 promotes cardiac repair by inhibiting the fibroblast to myofibroblast transition during fibrosis 0.97
Circular RNA-OGDH promotes PANoptosis in diabetic cardiomyopathy: A novel mechanistic insight 1.00
Cathepsin K as a key regulator of myocardial fibrosis in dilated cardiomyopathy and a promising therapeutic target 1.00
Colchicine inhibits vascular calcification by suppressing inflammasome activation through the enhancement of the Sirt2-PP2Ac signaling pathway 1.00
The macrophage sterol transport protein ORP2 promotes cholesterol efflux and prevents foam cell formation and atherosclerosis 0.89
1 1.00
Inflammation-associated Lipidomic Signatures Prior to Carotid Artery Atherosclerosis in People Living With HIV 1.00
8 4.57
Physiological MplW514L expression in hematopoietic stem cell causes an essential thrombocythemia and progressive myelofibrosis 1.00
Loss of RPGR disrupts motile cilia and causes primary ciliary dyskinesia by affecting F-actin dynamics 0.53
A positive allosteric modulator of the β1AR with antagonist activity for catecholaminergic polymorphic ventricular tachycardia 0.24
Myeloid-mesenchymal crosstalk drives ARG1-dependent profibrotic metabolism via ornithine in lung fibrosis 0.04
Aggressive B-cell lymphomas retain ATR-dependent determinants of T-cell exclusion from the Germinal Center Dark Zone 0.01
E3 ubiquitin ligase Listerin regulates macrophage cholesterol efflux and atherosclerosis by targeting ABCA1 1.00
PIEZO1 mediates periostin+ myofibroblast activation and pulmonary fibrosis in mice 0.76
Asparagine endopeptidase cleaves apolipoprotein A1 and accelerates pathogenesis of atherosclerosis 1.00
5 0.40
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. 0.07
Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial. 0.05
Mosunetuzumab plus polatuzumab vedotin in transplant-ineligible refractory/relapsed large B-cell lymphoma: primary results of the phase 3 SUNMO trial. 0.07
Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321). 0.11
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma. 0.10
2 2.00
Heterozygous human JAK2V617F activates AhR to drive essential thrombocythemia and promote thrombosis 1.00
Ciliated cell–derived IL-17D restrains allergic asthma through controlling monocyte recruitment 1.00
3 0.40
Human‐derived cardiac‐neural microtissues reveal catecholaminergic polymorphic ventricular tachycardia is also a disease of the sympathetic neuron 0.25
Anti‐arrhythmic targeting of sympathetic stellate ganglion P2X3 receptors 0.09
Hyperglycaemia‐induced reactive oxygen species production in cardiac ventricular myocytes differs among mammals 0.06
16 14.87
Posterior wall thickness associates with outcomes after septal myectomy in childhood hypertrophic obstructive cardiomyopathy——original article 1.00
The influence of reoperation on aortic arch reconstructive surgery: Evidence from a multicenter, national registry 0.03
Valve characteristics and surgical options for severe rheumatic mitral stenosis with more than mild regurgitation: A dual-center retrospective study 1.00
A novel rat model for group 2 pulmonary hypertension by total pulmonary vein banding: Multi-omics insights into pathophysiological mechanisms 1.00
Type A aortic dissection during pregnancy and postpartum: Experience in 60 patients over 25 years 0.93
Mitral valve repair versus bioprosthetic replacement outcomes in patients with rheumatic disease over 60: Propensity score–matching results 1.00
Early outcomes of chimney commando procedure in redo double valve replacement: A retrospective cohort study 1.00
Totally thoracoscopic transmitral versus transaortic septal myectomy for hypertrophic cardiomyopathy: A propensity score−matched comparative study 1.00
Reversed septal motion in congenital corrected transposition of the great arteries: A potential mechanism for tricuspid regurgitation 1.00
Device closure versus surgical repair for doubly committed subarterial ventricular septal defect 1.00
Symptomatic Myocardial Bridge: Long-term Outcomes and Strategies 1.00
Predictors and Prognosis of Mild Regurgitation After Rheumatic Mitral Valve Repair: A Dual-Center Cohort Analysis Based on Cardiac Computer Tomography 1.00
Impact of post-operative left bundle branch block on left ventricular remodeling following transapical beating-heart septal myectomy 0.92
The Fate of Aortic Valve after Surgical Repair for Discrete Membranous Subaortic Stenosis in Pediatric Patients 1.00
Comparison of Fresh and Glutaraldehyde-treated Autologous Pericardial Patch in Tricuspid Valve Repair: A Long-term Porcine Study 1.00
Prediction of sudden death in obstructive hypertrophic cardiomyopathy after septal myectomy: Targeting the candidate 1.00
17 13.69
Randomized Trial of Left Bundle Branch Pacing vs Right Ventricular Pacing in Vulnerable Cardiac Function 1.00
Blood Pressure Trajectories and Cardiovascular Outcomes in Older Patients 1.00
Long-Term Cardiovascular and Noncardiovascular Mortality After Acute Coronary Syndrome 1.00
Cardiomyopathy Gene Variants and Polygenic Risk Scores in Atrial Fibrillation 0.03
Real-Time Heart Team for Revascularization in Complex Coronary Artery Disease 1.00
Blood Pressure Levels and Outcomes in Type 2 Diabetes Dose-Response Meta-Analysis of 5.87 Million Cohort Participants 0.98
Pulsed Field Ablation Using a Novel Biphasic Catheter vs Thermal Ablation for Paroxysmal Atrial Fibrillation InsightPFA Trial 0.98
Proactive Management and Treatment of Aortic Stenosis: An International Expert Perspective 0.03
Drug-coated balloon angioplasty versus upfront stenting for de novo CAD: 3-year follow-up of REC-CAGEFREE I trial 0.83
Modest Effects of Intensive Blood Pressure–Lowering on Quality of Life in Patients at High Cardiovascular Risk The ESPRIT Trial 1.00
Intensive Blood Pressure Control in Older Patients With Hypertension 6-Year Results of the STEP Trial 0.96
Effects of Intensive Blood Pressure Control in Patients With Frailty A Post Hoc Analysis From ESPRIT 1.00
LDL-C related cardiovascular burden in China 2010-2030: Spatiotemporal patterns and scenario-based projections 1.00
Intensive vs Conventional Intraoperative Blood Pressure Management on Cardiovascular Events After Major Abdominal Surgery The BP-CARES Randomized Trial 0.85
Safety and Effectiveness of Statins for Primary Prevention in Adults With Type 1 Diabetes An Emulation 0.95
Effect of Intensive Blood Pressure Control on Stroke A Prespecified Secondary Analysis of the ESPRIT Trial 1.00
Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies 0.08
1 1.00
Worldwide Burden of Pulmonary Arterial Hypertension in Adults Aged 65 Years and Older From 1990 to 2021 1.00
2 1.08
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both: Post Hoc Analyses of CONFIDENCE Trial. 0.08
LARP7 Protects Vascular Smooth Muscle Cell Contractile Phenotype in CKD by Coupling with P300. 1.00
1 1.00
Telomere recapping via gene therapy as a beneficial strategy for cardio-renal syndrome type 4 1.00
2 2.00
Inhalable Macrophage Membrane-Camouflaged Hyperbranched Polymeric Nanoparticles for Acute Lung Injury Treatment 1.00
Nanocatalytic Antioxidation Enables Aortic Endothelial Repair and Aortic Aneurysm Treatment 1.00
4 2.97
Engineered immunosuppressive dendritic cells protect against cardiac remodelling 1.00
Clinical application of base editing for treating β-thalassaemia 0.94
A neuronal architecture underlying autonomic dysreflexia 0.03
Epithelial cell membrane perforation induces allergic airway inflammation 1.00
64 58.28
A self-supervised electrocardiogram foundation model for empowering cardiovascular disease prediction and genetic factor discovery 1.00
Dietary intake and BCAA metabolism regulate pulmonary fibrosis through KDM4A-mediated epigenetic remodeling in male mice 1.00
Hdac11 promotes idiopathic pulmonary fibrosis through macrophage M2-type polarization and myofibroblast accumulation by inhibiting Parkin-dependent mitophagy 0.93
Cardiac reprogramming via transient overexpression of P-glycoprotein alleviates doxorubicin-induced cardiotoxicity in mice and pigs 1.00
SLC1A5 prevents aortic aneurysm and dissection by glutaminolytic-epigenetic orchestration of vascular smooth muscle cell homeostasis 0.92
PDK4 drives abdominal aortic aneurysm by promoting smooth muscle cell metabolic reprogramming and NLRP3-mediated pyroptosis 0.95
Macrophage Gsα promotes NLRP3 stability and its intervention attenuates abdominal aortic aneurysm in male mice 0.82
Targeting REV-ERBα/BNIP3 axis attenuates pulmonary arterial hypertension by repressing mitophagy in mice 1.00
Cardiomyocyte-derived GPX4 stabilizes BNIP3 to facilitate mitophagy and mitigate myocardial ischemia/reperfusion injury 1.00
Zanubrutinib-rituximab followed by shortened chemoimmunotherapy as frontline treatment for mantle cell lymphoma (CHESS): a phase II trial 1.00
Cardiomyocyte Cyclin-dependent kinase 9 directly binds to and phosphorylates NF-κB p65 subunit to drive cardiac inflammation and remodeling 1.00
Single-cell multiomics uncovers an endothelial mechanosensitive PIEZO1-IL-33 axis driving pulmonary fibrosis 0.97
Pyruvate metabolism enzyme Dlat induces mitochondria protein hyperacetylation to limit fatty acid oxidation in the HFpEF heart 1.00
Optical control of the cardiac rhythm with photoswitchable Na1.5 channel blockers 1.00
NPM3 functions as a lactyltransferase to promote necroptosis in male diabetic cardiomyopathy mice models via FASN transcription modulation 1.00
Restoration of RBM22 overcomes the transcriptional and epigenetic barriers of cardiomyocyte proliferation for heart regeneration 1.00
Amphotericin B promotes respiratory viral entry by enhancing late endosomal maturation and fusion via glucocerebrosidase-mediated ceramide remodeling 1.00
TWIST1 drives endothelial-to-mesenchymal-transition to stabilize atherosclerotic plaques 0.11
Tenascin C myofibroblasts exacerbate vascular neointimal hyperplasia by propagation of nerve-macrophage interactions in mice 1.00
A nanosystem targeting tissue inhibitor of metalloproteinase-1 for continuous spatiotemporal idiopathic pulmonary fibrosis therapy 1.00
Airway immune profiles and therapeutic implications of IGF1 in eosinophilic granulomatosis with polyangiitis 0.88
Gut microbiota-derived metabolite isovalerylcarnitine modulates salt sensitivity of blood pressure and incident hypertension: a multicenter dietary salt intervention trial 1.00
Evidence for Interleukin-17C governing interleukin-17A pathogenicity and promoting asthma endotype switching in bronchiectasis 1.00
Calcium channel blockers increase the risk of aortic aneurysm and dissection 1.00
IDH2 lactylation promotes angiogenesis in murine diabetic myocardial infarction via blocking Cav1-eNOS interaction 1.00
GSDME-dependent pyroptosis drives abdominal aortic aneurysm via promoting vascular senescence 1.00
Administrative-driven hierarchical management of atrial fibrillation on cardiovascular events: a prospective matched cohort study 1.00
MAT2A promotes atherosclerotic plaque vulnerability by mediating epigenetic reprogramming of macrophages 1.00
Molecular insights into ago-allosteric modulation at cysteinyl leukotriene receptor 2 1.00
Nano-functionalized probiotic treats atherosclerosis via inhibiting intestinal microbiota-TMA-TMAO axis 0.91
Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma 1.00
Echo-Vision-FM: a pre-training and fine-tuning framework for echocardiogram video vision foundation model 0.20
A conformal piezoelectric microsystem for demographic-adaptive and calibration-free cuffless blood pressure monitoring 1.00
Platelet-bioengineered hiPSC-sEVs achieve targeted repair of fibrotic sinoatrial node in preclinical SND models 1.00
Modifiable influencing factors and their joint effects on early- and late-onset coronary heart disease 0.80
Comprehensive profiling of smoke-induced T cells in mice implicates clonal γδT17 cells as a hallmark of COPD 1.00
A noninvasive machine learning model using a complete blood count for screening of primary vitreoretinal lymphoma 1.00
Extracellular matrix anchored neutrophils drive pulmonary fibrosis in mice 1.00
Deciphering age- and sex-specific patterns of coronary artery atherosclerosis from a large Chinese cohort 1.00
A heterogeneous-structure facial mask for thermal and humidity regulation in cold environments 1.00
Crystal structures of Ryanodine Receptor reveal dantrolene and azumolene interactions guiding inhibitor development 0.63
Regulation of lipoprotein processing by GPNMB in foamy macrophages: potential therapeutic targets for atherosclerosis 1.00
Ras-related protein 2 limits vascular smooth muscle cell phenotypic switching and abdominal aortic aneurysm development 1.00
CCL28 contributes to angiogenesis and cardiac repair through CCR10 endothelial cells after myocardial infarction in male mice 1.00
Chronic kidney disease is associated with increased risk of sudden cardiac death 1.00
The CCL20–integrin α5β1 interaction enhances TGF-β/Smad signaling to promote fibroblast activation in pulmonary fibrosis 1.00
Reprogramming mitochondrial metabolism and epigenetics of macrophages via miR-10a liposomes for atherosclerosis therapy 1.00
Adipocyte FMO3-derived TMAO induces WAT dysfunction and metabolic disorders by promoting inflammasome activation in ageing 0.93
An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: the DUBHE randomized clinical trial 1.00
Macrophage ferroptosis potentiates GCN2 deficiency induced pulmonary venous arterialization 1.00
Lymph nodes molecular subtypes unravel lymph nodes heterogeneity and clinical implications in colorectal cancer 1.00
Transparent artificial intelligence-enabled interpretable and interactive sleep apnea assessment across flexible monitoring scenarios 1.00
Cardiomyocyte OTUD1 drives diabetic cardiomyopathy via directly deubiquitinating AMPKα2 and inducing mitochondrial dysfunction 1.00
Inhibiting CD36 palmitoylation improves cardiac function post-infarction by regulating lipid metabolic homeostasis and autophagy 0.98
A programmable platelet theranostic platform for adaptive multi-stage delivery and synergistic immunotherapy in atherosclerosis 1.00
Cross-population GWAS and proteomics improve risk prediction and reveal mechanisms in atrial fibrillation 0.29
Association between self-reported multimorbidity and longitudinal brain Aβ deposition in Alzheimer’s disease 0.06
Multiplexed self-adaptable Janus hydrogels rescue epithelial malfunction to promote complete trachea repair 1.00
Stress granule assembly impairs macrophage efferocytosis to aggravate allergic rhinitis in mice 1.00
Metabolic reprogramming of the neovascular niche promotes regenerative angiogenesis in proliferative retinopathy 0.02
Myocardial mitochondrial antiviral signaling protein promotes heart Ischemia-reperfusion injury via RIG-I signaling in mice 0.89
Atrial fibrillation detection via contactless radio monitoring and knowledge transfer 1.00
Tifcemalimab as monotherapy or in combination with toripalimab in patients with relapsed/refractory lymphoma: a Phase I trial 1.00
Endothelial major vault protein alleviates vascular remodeling via promoting Parkin-mediated mitophagy 1.00
6 2.87
Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial 0.05
Socioeconomic and energy transition disparities in air pollution-related mortality across Europe 0.06
In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial 0.94
Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study 0.03
AI-based diagnosis of acute aortic syndrome from noncontrast CT 0.96
A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial 0.83
1 0.73
Effect of climate-driven childhood sleep erosion on potential regional economic inequality 0.73
1 1.00
Genome-wide analysis identifies susceptibility loci for heart failure and nonischemic cardiomyopathy subtype in the East Asian populations 1.00
5 4.36
Impact of abdominal obesity prevalence trends on dementia, cardiovascular disease, functional impairment, and mortality in older Chinese adults: A Markov scenario simulation, 2020–2050 0.50
Transformer-based deep learning model for real-time prediction of intraoperative hypotension using dynamic time-series vital signs: A retrospective study 1.00
The impact of the Lancet Commission definition of obesity on its prevalence and implications on long-term cardiovascular-kidney-metabolic outcomes in East Asians: Observational study of two community-based cohorts 0.92
Analysis of inter-hospital transfer on clinical outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A secondary analysis of the BRIGHT-4 trial 0.94
Absolute risk-based versus individualized benefit approaches for determining statin eligibility in primary prevention of cardiovascular diseases in Chinese populations: A modeling study 1.00
8 6.85
Purine metabolic adaptation protects the endothelium from disturbed flow–induced DNA damage and atherosclerosis 0.27
Retinol saturase in the mitochondria antagonizes IDH2 and GLUD1 acetylation to mediate heart repair 1.00
TRIM21enhances IL-17A signaling and drives autoimmune myocarditis by promoting TRAF3 lysosomaldegradation in cardiac fibroblasts 0.92
Calumenin prevents fibroblast senescence and lung aging by promoting vimentin proteostasis 0.91
Myeloid GPSM1 regulates atherosclerosis progression by governing monocyte and macrophage activation and chemotaxis 1.00
Inequality in air pollution–attributable mortality by income level between and within countries 0.75
Serum metabolic patterns reveal the diagnostic and prognostic role of alanine abnormality in ocular adnexal lymphoma 1.00
Setdb1 ablation in macrophages attenuates fibrosis in heart allografts 1.00
8 7.71
A Fully Automated Deep Learning Model for Quantifying Coronary Plaque at Coronary CT Angiography. 1.00
Evaluation of Supracardiac Atherosclerosis in Stroke with a Noncontrast Head-Neck-Aortic Vessel Wall MRI. 1.00
Machine Learning Using Clinical and Cardiac MRI Features to Predict Long-term Outcomes in Acute STEMI. 1.00
Super-Resolution Deep Learning Reconstruction for Coronary CT Angiography: Coronary Stenosis Assessment and CAD-RADS Reclassification. 0.96
Drug-coated Balloon for Endovascular Treatment of Symptomatic Intracranial Stenotic Disease: A Multicenter Randomized Controlled Trial. 0.96
Dynamic Chest Radiography as an Alternative to Pulmonary Function Tests for Chronic Obstructive Pulmonary Disease. 1.00
Left Atrial Minimum Volume Index at Cardiac MRI Predicts Adverse Outcomes after Acute Myocardial Infarction. 1.00
Right Ventricular Strain Improves Cardiac MRI-based Prognostication in Heart Failure with Preserved Ejection Fraction. 0.79
7 6.84
PARP1 stabilizes FOXN3 to suppress pulmonary fibrosis through p38-related feedback regulation 0.91
An ultrasmall theranostic nanozyme for abdominal aortic aneurysm management and therapeutic efficacy monitoring 1.00
PIEZO1 gain-of-function mutation drives cardiomyopathy by disrupting myocardial lipid homeostasis besides iron overload 1.00
AIBP-LRP2–mediated HDL uptake restricts CXCR4+ stemlike capillary expansion and collateral circulation 0.93
Simultaneous imaging of bidirectional guided waves probes arterial mechanical anisotropy, blood pressure, and stress synchronously 1.00
Biomimetic targeted self-adaptive nanodrug for inflammation optimization and AT2 cell modulation in precise ARDS therapy 1.00
BRD4770 protects against DOX-induced cardiotoxicity by inhibiting apoptosis and ferroptosis 1.00
2 2.00
Chaperone-mediated autophagy supports organ regeneration and fibroblast quiescence in mouse models of fibrosis 1.00
Sine oculis homeobox 1 drives endothelial dysfunction in preclinical pulmonary arterial hypertension 1.00
1 0.73
Impact of shifting blood donation policy from gift to honour model: staggered difference-in-differences analysis in China 0.73
1 0.86
A fibroblast-like endothelial cell state promotes atherosclerosis via C/EBPβ-activated TGF-β signaling 0.86
1 1.00
Olsenella scatoligenes-derived skatole promotes smooth muscle cell proliferation and migration to aggravate atherosclerosis 1.00
4 2.12
Eosinophilic chronic rhinosinusitis with nasal polyps: Squamous metaplasia as an associated remodeling feature 1.00
Club Cell RhoA Activation Amplifies Allergic Airway Inflammation by Regulating Epithelial Integrity and C1qα+ Interstitial Macrophages 0.10
The role of CC16 in the associations of preterm birth with lung function and asthma in adult life 0.02
Brg1-imprinted chromatin status controls the effector and memory ILC2 metabolism to exacerbate allergic lung inflammation 1.00
4 1.08
Prediction of mortality, bleeding, and ischaemic events in patients with cancer and acute coronary syndrome: a model development and validation study 0.02
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial 0.07
Benefit–harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials 0.96
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial 0.03
1 0.95
Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial 0.95
6 2.17
Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation 0.03
Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage 0.05
Randomized Trial of Adjunctive Prednisolone for Kawasaki Disease 0.98
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia 1.00
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation 0.07
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk 0.04
7 5.07
Short-term effects of size-fractioned particulate matter on blood pressure in patients with COPD: the key role of inflammatory phenotypes 0.85
Transcriptomic signatures of IPF in ALI-cultured airway cells and their therapeutic implications 0.01
Proteomics-based risk prediction and drug targets identification for chronic obstructive pulmonary disease 1.00
Adherence to the EAT-Lancet diet, plasma proteomics and the risk of chronic obstructive pulmonary disease 0.88
Efficacy and safety of novel airway balloon cryoablation system for malignant central airway obstruction: a prospective, multicentre, randomised, non-inferiority study 1.00
PM2.5 as a risk factor for sleep oxygen desaturation in COPD: identifying susceptible individuals by smoking and inflammatory phenotypes 0.82
Circulating miRNAs and childhood asthma ICS response: a stratified analysis in the intervention arm of an RCT with vitamin D effect modification 0.51

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.